Meadow Creek Investment Management’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$3.96M Sell
153,692
-4,844
-3% -$147K 0.08% 224
2019
Q2
$4.66M Buy
158,536
+59,248
+60% +$1.71M 0.09% 200
2019
Q1
$3.4M Sell
99,288
-784
-0.8% -$27.7K 0.07% 246
2018
Q4
$3.19M Sell
100,072
-672
-0.7% -$26.2K 0.07% 245
2018
Q3
$4.84M Buy
100,744
+16,660
+20% +$682K 0.1% 200
2018
Q2
$2.61M Buy
84,084
+2,268
+3% +$53.1K 0.06% 285
2018
Q1
$1.21M Hold
81,816
0.03% 378
2017
Q4
$1.27M Buy
81,816
+14,672
+22% +$218K 0.03% 403
2017
Q3
$836K Sell
67,144
-7,196
-10% -$80.2K 0.02% 462
2017
Q2
$803K Sell
74,340
-21,588
-23% -$211K 0.02% 463
2017
Q1
$940K Hold
95,928
0.02% 408
2016
Q4
$1.04M Buy
+95,928
New +$976K 0.03% 368

Other funds holding STAA

Meadow Creek Investment Management's STAA Position: Q3 2019 in Review

Meadow Creek Investment Management reduced its STAAR Surgical (STAA) stake by 3.1% in Q3 2019, selling an estimated $147K and leaving 153,692 shares worth $3.96M. The position accounts for 0.08% of the portfolio, ranked #224.

Meadow Creek Investment Management first reported a position in STAA in Q4 2016 and has held it in 12 quarters since. The position peaked at $4.84M in Q3 2018. 152 funds tracked by Wall St. Rank hold STAA as of Q3 2019.

  • Meadow Creek Investment Management held 153,692 shares of STAAR Surgical worth $3.96M as of Q3 2019.
  • Meadow Creek Investment Management sold 4,844 STAAR Surgical shares in Q3 2019, an estimated $147K.
  • STAAR Surgical made up 0.08% of Meadow Creek Investment Management's portfolio in Q3 2019, its #224 holding.
  • Meadow Creek Investment Management first reported a position in STAAR Surgical in Q4 2016 and has held it in 12 quarters since.
  • Meadow Creek Investment Management's STAAR Surgical position peaked at $4.84M in Q3 2018.
  • 152 funds tracked by Wall St. Rank held STAAR Surgical as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.